Today's hip edition covers four compelling studies examining total hip arthroplasty outcomes, fracture recovery predictors, healthcare system performance, and mortality biomarkers. We explore dual-mobility versus conventional implants in ankylosing spondylitis patients, the role of inflammatory markers in predicting functional recovery after hip fracture, Greece's first national hip fracture registry findings, and a novel biomarker for risk stratification in femoral fracture patients.
"Functional Outcomes of Dual-Mobility versus Fixed-Bearing Primary Total Hip Arthroplasty in Ankylosing Spondylitis Patients with Hip Involvement: A Retrospective Cohort Study" — Obeid AAI et al., Orthop Res Rev — https://doi.org/10.2147/ORR.S574795"Association between chronic inflammation and poorer long-term functional recovery post-hip fracture in and between men and women" — Eastlack M et al., JBMR Plus — https://doi.org/10.1093/jbmrpl/ziag019"Distinct Characteristics of Patients With Fragility Hip Fracture in Greece: Evidence From the Greek National Fragility Hip Fracture Registry Utilizing the Minimum Common Data Set" — Iliopoulos E et al., Cureus — https://doi.org/10.7759/cureus.103990"Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) as a Predictor of Mortality in Patients with Femoral Fracture: A Retrospective Cohort Analysis" — Kuo PJ et al., Ther Clin Risk Manag — https://doi.org/10.2147/TCRM.S553629